Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in  a Phase III Adjuvant Trial of Capecitabine

Publication date: 2016 Source:Breast Diseases: A Year Book Quarterly, Volume 27, Issue 3 Author(s): A.S. Rosenstock, G.N. Hortobagyi

Source: Breast Diseases: A Year Book Quarterly - August 25, 2016 Category: Cancer & Oncology Source Type: research